CJC-1295 2mg
Long-Acting GHRH Analog | Drug Affinity Complex | 2mg Lyophilised Powder
About CJC-1295 2mg
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH). The DAC modification — a lysine-maleimidoproprionic acid linkage — allows the peptide to bind reversibly to albumin, dramatically extending its half-life. Unlike CJC-1295 without DAC, this compound produces a sustained GH 'bleed' rather than a sharp pulse — a critical distinction for long-duration in-vitro study designs.
Research Applications
- GH axis restoration and growth hormone secretion modelling
- IGF-1 production and signalling pathway studies
- Lean muscle tissue growth and anabolic signalling assays
- Adipose tissue reduction and metabolic rate regulation research
- Bone density and cellular repair pathway modelling
Technical Specifications
| Molecular Weight | 3647.28 g/mol |
| Purity | ≥98% (HPLC verified) |
| Form | Lyophilised powder |
| Half-life | ~6–8 days (DAC modification) |
| Storage | -20°C, protected from light |
| Quantity | 2mg per vial |
Certificate of Analysis
All compounds supplied by Monumental Peptides are independently tested by a third-party laboratory using HPLC and Mass Spectrometry, with purity confirmed at ≥98%. Certificates of Analysis are available upon request — simply contact us after placing your order.
Request Certificate of Analysis →Related Research Compounds
Ready to Order CJC-1295 2mg?
UK stock · Fast dispatch · Full documentation included
Order Now — £27.99 →